390 related articles for article (PubMed ID: 28414772)
41. In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape.
García-Álvarez R; Hadjidemetriou M; Sánchez-Iglesias A; Liz-Marzán LM; Kostarelos K
Nanoscale; 2018 Jan; 10(3):1256-1264. PubMed ID: 29292433
[TBL] [Abstract][Full Text] [Related]
42. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
[TBL] [Abstract][Full Text] [Related]
43. Protein deglycosylation can drastically affect the cellular uptake.
Ghazaryan A; Landfester K; Mailänder V
Nanoscale; 2019 Jun; 11(22):10727-10737. PubMed ID: 31120044
[TBL] [Abstract][Full Text] [Related]
44. Improving dispersal of therapeutic nanoparticles in the human body.
Limongi T; Canta M; Racca L; Ancona A; Tritta S; Vighetto V; Cauda V
Nanomedicine (Lond); 2019 Apr; 14(7):797-801. PubMed ID: 30895871
[No Abstract] [Full Text] [Related]
45. The Protein Corona around Nanoparticles Facilitates Stem Cell Labeling for Clinical MR Imaging.
Nejadnik H; Taghavi-Garmestani SM; Madsen SJ; Li K; Zanganeh S; Yang P; Mahmoudi M; Daldrup-Link HE
Radiology; 2018 Mar; 286(3):938-947. PubMed ID: 29091749
[TBL] [Abstract][Full Text] [Related]
46. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
Xiao W; Gao H
Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
[TBL] [Abstract][Full Text] [Related]
47. Effect of the Protein Corona on Antibody-Antigen Binding in Nanoparticle Sandwich Immunoassays.
de Puig H; Bosch I; Carré-Camps M; Hamad-Schifferli K
Bioconjug Chem; 2017 Jan; 28(1):230-238. PubMed ID: 28095684
[TBL] [Abstract][Full Text] [Related]
48. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.
Tenzer S; Docter D; Rosfa S; Wlodarski A; Kuharev J; Rekik A; Knauer SK; Bantz C; Nawroth T; Bier C; Sirirattanapan J; Mann W; Treuel L; Zellner R; Maskos M; Schild H; Stauber RH
ACS Nano; 2011 Sep; 5(9):7155-67. PubMed ID: 21866933
[TBL] [Abstract][Full Text] [Related]
49. Comparative study on formation of protein coronas under three different serum origins.
Lee SY; Son JG; Moon JH; Joh S; Lee TG
Biointerphases; 2020 Nov; 15(6):061002. PubMed ID: 33187398
[TBL] [Abstract][Full Text] [Related]
50. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.
Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ
ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593
[TBL] [Abstract][Full Text] [Related]
51. Protein Corona Analysis of Silver Nanoparticles Links to Their Cellular Effects.
Juling S; Niedzwiecka A; Böhmert L; Lichtenstein D; Selve S; Braeuning A; Thünemann AF; Krause E; Lampen A
J Proteome Res; 2017 Nov; 16(11):4020-4034. PubMed ID: 28929768
[TBL] [Abstract][Full Text] [Related]
52. Formation and biological effects of protein corona for food-related nanoparticles.
Cui G; Su W; Tan M
Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):2002-2031. PubMed ID: 34716644
[TBL] [Abstract][Full Text] [Related]
53. Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells.
Chandran P; Riviere JE; Monteiro-Riviere NA
Nanotoxicology; 2017 May; 11(4):507-519. PubMed ID: 28420299
[TBL] [Abstract][Full Text] [Related]
54. Soft and Hard Interactions between Polystyrene Nanoplastics and Human Serum Albumin Protein Corona.
Kihara S; van der Heijden NJ; Seal CK; Mata JP; Whitten AE; Köper I; McGillivray DJ
Bioconjug Chem; 2019 Apr; 30(4):1067-1076. PubMed ID: 30821961
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticle-protein corona complex: understanding multiple interactions between environmental factors, corona formation, and biological activity.
Tomak A; Cesmeli S; Hanoglu BD; Winkler D; Oksel Karakus C
Nanotoxicology; 2021 Dec; 15(10):1331-1357. PubMed ID: 35061957
[TBL] [Abstract][Full Text] [Related]
56. Preparation of the protein corona: How washing shapes the proteome and influences cellular uptake of nanocarriers.
Brückner M; Simon J; Jiang S; Landfester K; Mailänder V
Acta Biomater; 2020 Sep; 114():333-342. PubMed ID: 32726673
[TBL] [Abstract][Full Text] [Related]
57. Role of structural specificity of ZnO particles in preserving functionality of proteins in their corona.
Singh U; Saifi Z; Kumar M; Reimers A; Krishnananda SD; Adelung R; Baum M
Sci Rep; 2021 Aug; 11(1):15945. PubMed ID: 34354203
[TBL] [Abstract][Full Text] [Related]
58. Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles.
Ban Z; Yuan P; Yu F; Peng T; Zhou Q; Hu X
Proc Natl Acad Sci U S A; 2020 May; 117(19):10492-10499. PubMed ID: 32332167
[TBL] [Abstract][Full Text] [Related]
59. Polymeric Nanoparticles with Neglectable Protein Corona.
Alberg I; Kramer S; Schinnerer M; Hu Q; Seidl C; Leps C; Drude N; Möckel D; Rijcken C; Lammers T; Diken M; Maskos M; Morsbach S; Landfester K; Tenzer S; Barz M; Zentel R
Small; 2020 May; 16(18):e1907574. PubMed ID: 32250017
[TBL] [Abstract][Full Text] [Related]
60. Protein corona formation and its constitutional changes on magnetic nanoparticles in serum featuring a polydehydroalanine coating: effects of charge and incubation conditions.
Gräfe C; von der Lühe M; Weidner A; Globig P; Clement JH; Dutz S; Schacher FH
Nanotechnology; 2019 Jun; 30(26):265707. PubMed ID: 30861506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
